AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Revoglip-M 500 Tablet SR

Prescription Icon
Prescription Required

Marketer

Zuventus Healthcare Ltd

Salt Composition

Metformin (500mg) + Teneligliptin (20mg)

Overview Revoglip-M 500 Tablet SR

Diabetic patients with type 2 mellitus may find relief with the dual-action formulation of Revoglip-M 500 SR tablets. This medication effectively manages elevated blood glucose, mitigating the risk of severe diabetic complications such as renal impairment and vision loss. Furthermore, it can potentially lessen the probability of cardiovascular events like heart attacks or strokes. Revoglip-M 500 SR may be used independently or in conjunction with other anti-diabetic therapies. Optimal efficacy is achieved when combined with a balanced diet and regular physical activity. Dosage is individualized based on the patient's condition, glycemic readings, and existing medications. Consuming this medication with meals minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes therapeutic benefits; cessation should only occur under medical supervision. Maintaining controlled blood sugar levels proactively reduces future complications. Adherence to the physician-prescribed diet and exercise regimen is crucial for successful diabetes management; lifestyle significantly influences disease control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, and headache. Hypoglycemia, a potential adverse event, particularly when used with insulin or sulfonylureas, necessitates awareness of its symptoms and management. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women require medical consultation before use. Potential drug interactions necessitate disclosure of all current medications to ensure patient safety. Alcohol should be avoided due to its hypoglycemic effects. Kidney function and blood glucose levels are monitored regularly by your doctor throughout treatment.

Uses of Revoglip-M 500 Tablet SR

Managing Type 2 diabetes

Major Benefits of Revoglip-M 500 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Consume Revoglip-M 500 SR tablets with a meal.

Common Side effects of Revoglip-M 500 Tablet SR:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Revoglip-M 500 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take Revoglip-M 500 Tablet SR with a meal.

How Revoglip-M 500 Tablet SR works:

Extended-release Revoglip-M 500 tablets contain a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Revoglip-M 500 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Revoglip-M 500 SR tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against the risks before prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Revoglip-M 500 SR tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability while taking Revoglip-M 500 Tablet SR is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with kidney impairment should use Revoglip-M 500 SR tablets cautiously, potentially requiring dosage modification under medical supervision. Revoglip-M 500 SR tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Use of Revoglip-M 500 SR tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Physician consultation is recommended.

What if you forget to take Revoglip-M 500 Tablet SR :

Should you forget to take a Revoglip-M 500 Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Revoglip-M 500 Tablet SR

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Revoglip-M 500 Tablet SR

Revoglip-M 500 Tablet SR is safe when used as directed by your doctor. However, even with proper usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar) may occur. Hypoglycemia is more likely if you're also taking insulin or sulfonylurea. Report any persistent issues to your doctor.
Revoglip-M 500 Tablet SR rarely causes hypoglycemia by itself; however, insufficient caloric intake while using this medication may lead to low blood sugar. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness can occur, especially if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting glucose source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Revoglip-M 500 Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Always consult your doctor before taking any other medication.
Revoglip-M 500 Tablet SR is contraindicated in patients allergic to its components or excipients. Its use is also harmful for those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Revoglip-M 500 Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect involving elevated blood lactic acid. It's avoided in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Revoglip-M 500 Tablet SR and seek immediate medical attention.
Prolonged use of Revoglip-M 500 Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. If you experience these symptoms, consult your doctor for B12 level monitoring and potential supplementation.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Revoglip-M 500 Tablet SR
95
MRP 110
13% off